of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27 Notification of the resignation of Chairman of the Audit

Committee, Appointment of Audit Committee, Appointment of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27

issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures

decreased to 0.85% when compared to previous year. It gained from the sales of low cost merchandise which was in higher portion. Total cost of sales and administrative expense were 618.64 million baht, it

the issuer’s core business. In any event, the issuer must not operate business in such a way that involves severely illegal business. For example, human trafficking, drug production or smuggling, or

to take action against alleged insider trading of certain listed securities where a group of persons gained multi-million baht of benefits by purchasing such securities with information on change of

trading shares in the SET. He also gained benefits from which his IFEC shares of more than 57.46 million used as the collateral for his margin trading were not subject to force selling. As a result, he

goods. Distribution cost and administrative expenses amount to Baht 108.53 million. It decreased Baht 14.12 million or equivalent to 11.51% which gained from the expenditure adjustment to the categories

(“GLOBAL”) through the securities trading accounts of six persons and gained benefits from such transactions. The purchases were made in such a way that taking advantage of others by using non-public

became publicly known on February 28, 2014. Such action was deemed taking an unfair advantage of other people, and Chai gained benefits indirectly from such other persons’ purchases of BKI shares. SEC